P.A.W. Capital Corp Grows Position in DocGo Inc. (NASDAQ:DCGO)

P.A.W. Capital Corp increased its position in DocGo Inc. (NASDAQ:DCGO - Free Report) by 50.0% in the 4th quarter, according to its most recent filing with the SEC. The fund owned 900,000 shares of the company's stock after purchasing an additional 300,000 shares during the period. DocGo accounts for about 12.2% of P.A.W. Capital Corp's holdings, making the stock its 2nd biggest holding. P.A.W. Capital Corp owned 0.87% of DocGo worth $5,031,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also made changes to their positions in DCGO. Deerfield Management Company L.P. Series C increased its position in DocGo by 55.7% in the 3rd quarter. Deerfield Management Company L.P. Series C now owns 4,764,000 shares of the company's stock valued at $25,392,000 after acquiring an additional 1,705,000 shares during the period. State Street Corp increased its position in DocGo by 352.2% in the 2nd quarter. State Street Corp now owns 1,660,004 shares of the company's stock valued at $11,852,000 after acquiring an additional 1,292,941 shares during the period. WCM Investment Management LLC increased its position in DocGo by 77.6% in the 3rd quarter. WCM Investment Management LLC now owns 2,234,689 shares of the company's stock valued at $12,000,000 after acquiring an additional 976,656 shares during the period. Sectoral Asset Management Inc. acquired a new position in DocGo in the 3rd quarter valued at about $3,472,000. Finally, Northern Trust Corp increased its position in DocGo by 425.3% in the 2nd quarter. Northern Trust Corp now owns 698,573 shares of the company's stock valued at $4,989,000 after acquiring an additional 565,582 shares during the period. 56.44% of the stock is owned by hedge funds and other institutional investors.

DocGo Stock Down 2.8 %

Shares of DCGO stock traded down $0.10 on Friday, reaching $3.26. 1,058,568 shares of the stock were exchanged, compared to its average volume of 1,600,399. The stock has a market cap of $339.59 million, a P/E ratio of 45.71, a price-to-earnings-growth ratio of 0.34 and a beta of 0.91. The firm has a 50 day moving average of $3.74 and a two-hundred day moving average of $4.71. DocGo Inc. has a 1-year low of $2.78 and a 1-year high of $10.82.

DocGo (NASDAQ:DCGO - Get Free Report) last released its quarterly earnings data on Wednesday, February 28th. The company reported $0.06 EPS for the quarter, missing analysts' consensus estimates of $0.13 by ($0.07). The firm had revenue of $199.25 million for the quarter, compared to analyst estimates of $195.48 million. DocGo had a return on equity of 2.01% and a net margin of 1.10%. On average, equities research analysts predict that DocGo Inc. will post 0.35 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

Several equities analysts recently issued reports on DCGO shares. BTIG Research dropped their price target on DocGo from $13.00 to $11.00 and set a "buy" rating on the stock in a research report on Wednesday. Canaccord Genuity Group lowered their price target on DocGo from $10.00 to $9.00 and set a "buy" rating on the stock in a report on Thursday. Cantor Fitzgerald lowered their price target on DocGo from $13.00 to $11.00 and set an "overweight" rating on the stock in a report on Thursday, February 29th. Stifel Nicolaus reduced their target price on DocGo from $11.00 to $8.00 and set a "buy" rating on the stock in a research note on Wednesday. Finally, Needham & Company LLC reduced their target price on DocGo from $14.00 to $10.00 and set a "buy" rating on the stock in a research note on Thursday, February 29th. Five research analysts have rated the stock with a buy rating, Based on data from MarketBeat.com, the stock has an average rating of "Buy" and an average target price of $10.83.

Insider Activity at DocGo

In other DocGo news, Director Michael J. Burdiek bought 10,000 shares of the stock in a transaction dated Thursday, March 14th. The stock was bought at an average cost of $3.61 per share, for a total transaction of $36,100.00. Following the completion of the purchase, the director now directly owns 571,595 shares of the company's stock, valued at $2,063,457.95. The acquisition was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. 13.78% of the stock is owned by insiders.

DocGo Profile

DocGo Inc provides mobile health and medical transportation services for various health care providers in the United States and the United Kingdom. The company's transportation services include emergency response services; and non-emergency transport services comprise ambulance and wheelchair transportation services.